002800 — Sinsin Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Market Cap
KR₩81bn
Enterprise Value
KR₩125bn
Revenue
KR₩103bn

Annual balance sheet for Sinsin Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,410	2,504	799	2,240	346
Net Total Accounts Receivable
Net Total Receivables	25,944	24,005	24,890	27,724	30,191
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	44,589	39,680	36,467	45,048	47,108
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	80,219	70,034	69,345	66,825	68,264
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	129,238	118,134	114,307	121,213	124,409
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	34,782	34,382	33,919	42,327	51,720
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	72,875	61,939	59,381	61,515	62,114
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	56,363	56,195	54,927	59,698	62,295
Total Liabilities & Shareholders' Equity	129,238	118,134	114,307	121,213	124,409
Total Common Shares Outstanding